# Cooper Companies Moat

Status: stale. Policy: company-analysis-1.

Cooper has existing regulatory approvals, intellectual property, technical know-how and a differentiated contact lens portfolio. These establish a competitive franchise, but the supplied passages do not establish durable superiority over established rivals, customer lock-in or a cost advantage. Pricing discretion faces existing contractual constraints and reported competitive pressure. Continued demand and cash generation coexist with CooperVision's third-quarter stagnation, manufacturing cost pressure and substantial recall litigation expense. This is insufficient evidence of a durable moat, rather than proof of a structurally weak business.

## intangible_assets

Existing product approvals, patents and technical know-how support current market participation and differentiation. CooperVision's broad lens parameters reportedly improve fitting outcomes, but that comparative benefit is an issuer assertion and does not establish a durable moat.

Durability: Regulatory development and approval can take years, supporting barriers to new entry. Patent scope, expiration dates and the difficulty of matching Cooper's products are undisclosed; established competitors already operate within these barriers.

Risks: Competitive innovation, contractual pricing pressure and product quality failures can erode differentiation. The recall and litigation expense are realized setbacks; future technological substitution remains a possibility.

Invalidation: The candidate advantage would be undermined by loss of material approvals or enforceable intellectual property, competitors matching lens breadth and fitting outcomes, or sustained organic sales and customer losses requiring greater discounts. Conversely, demonstrated persistent product superiority and repeat demand despite pricing pressure would strengthen the moat case.

Competitors: Johnson & Johnson Vision Care, Inc., Alcon Inc., Bausch + Lomb, Vitrolife Group
- [https://www.sec.gov/Archives/edgar/data/711404/000162828025055615/coo-20251031.htm](https://www.sec.gov/Archives/edgar/data/711404/000162828025055615/coo-20251031.htm) · 2025-12-05
- [https://www.sec.gov/Archives/edgar/data/711404/000162828026061160/coo-20260731.htm](https://www.sec.gov/Archives/edgar/data/711404/000162828026061160/coo-20260731.htm) · 2026-09-09
- [https://www.sec.gov/Archives/edgar/data/711404/000162828026011110/coo-20260224.htm](https://www.sec.gov/Archives/edgar/data/711404/000162828026011110/coo-20260224.htm) · 2026-02-24
- [https://www.sec.gov/Archives/edgar/data/711404/000071140424000074/coo-20241031.htm](https://www.sec.gov/Archives/edgar/data/711404/000071140424000074/coo-20241031.htm) · 2024-12-06
- [https://www.sec.gov/Archives/edgar/data/711404/000071140423000072/coo-20231031.htm](https://www.sec.gov/Archives/edgar/data/711404/000071140423000072/coo-20231031.htm) · 2023-12-08
- [https://www.sec.gov/Archives/edgar/data/711404/000162828026041305/coo-20260430.htm](https://www.sec.gov/Archives/edgar/data/711404/000162828026041305/coo-20260430.htm) · 2026-06-05
- [https://www.sec.gov/Archives/edgar/data/711404/000162828026061155/cooperq32026pressrelease.htm](https://www.sec.gov/Archives/edgar/data/711404/000162828026061155/cooperq32026pressrelease.htm) · 2026-09-09
- [https://www.sec.gov/Archives/edgar/data/711404/000162828026061155/cooperq32026pressreleaseex.htm](https://www.sec.gov/Archives/edgar/data/711404/000162828026061155/cooperq32026pressreleaseex.htm) · 2026-09-09
- [https://www.sec.gov/Archives/edgar/data/711404/000162828026040823/cooperq22026pressrelease.htm](https://www.sec.gov/Archives/edgar/data/711404/000162828026040823/cooperq22026pressrelease.htm) · 2026-06-04
- [https://www.sec.gov/Archives/edgar/data/711404/000162828026015231/cooperq12026pressrelease.htm](https://www.sec.gov/Archives/edgar/data/711404/000162828026015231/cooperq12026pressrelease.htm) · 2026-03-05

[JSON](https://beanvest.com/stock/coo/moat.json)